Due to street closure, we will be closed on Saturday, August 30th and will reopen Tuesday, September 2nd.
Patient Resources
Get Healthy!
Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis
- April 9, 2025
- HealthDayTV HealthDay Reporter
Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.
